in the news articles ↓

 

novel tetracycline from Warner Chilcott and Paratek

Some very preliminary internet crumbs about a new possible rosacea treatment under development. The treatment under development is listed as a “novel tetracycline”. Warner Chilcott Limited calls itself a “specialty pharmaceutical company, that engages in the development, manufacture, marketing, and sale of branded prescription pharmaceutical products in women’s healthcare and dermatology segments primarily in the United States”. In the WCRX 2007 Annual …

 

Glyco Mira developing anti-cathelicidin treatment ?

A brief paragraph in a recent article in The Salt Lake Tribune looks quite interesting. A company called Glyco Mira (seemingly a company without a web site) is developing a drug that “may be able to cure the underlying problem that causes rosacea”. A pretty tall prediction for sure. So what are they talking about ? Glyco Mira have licensed and anti-inflammatory drug from the …

 

Pyratine XR launches, user reviews

Showing just how important the internet is becoming for marketing new cosmetics, Pyratine XR has recently launched with a lot of press activity. As well as Senetek’s press releases on the internet I was also contacted by 2 …

 

Video Tips from Rosacea Rescue Squad

The Galderma rosacea promotional site Best Face Forward has a new section titled Rosacea Rescue Squad. The site features some video tips from Dr. Hilary Baldwin and Charla Krupp. Dr. Baldwin, who is a dermatologist from …

 

GlaxoSmithKline to buy Stiefel (Rosac/Rosasol)

Continuing recent consolidations in the pharmaceutical industry is the report that the giant GlaxoSmithKline (or GSK) are to purchase Stiefel. Stiefel is the manufacturer of …